Le Lézard
Subject: PER

Former Federal District Court Judge Nancy Gertner Joins Leading Whistleblower Law Firm

WASHINGTON, Jan. 14, 2019 /PRNewswire/ -- Former U.S. District Court Judge and current Harvard Law School lecturer Nancy Gertner has joined one of the nation's leading whistleblower and complex litigation boutique firms, Guttman, Buschner & Brooks (GBB), as of counsel.

Nancy Gertner is a former U.S. federal judge who built her career around standing up for womenís rights, civil liberties and justice for all. She retired from the bench in 2011 to teach at Harvard Law School. She is pictured in Langdell Hall at Harvard University. Stephanie Mitchell/Harvard Staff Photographer

Lawyers at Guttman, Buschner & Brooks, with offices in Washington, D.C., Bala Cynwyd, PA, and Wilmington, DE, have represented whistleblowers in cases returning nearly $6 billion to Federal and State governments. In July of 2017, on the eve of trial, the firm settled a non-intervened False Claims case with Celgene for $280 million. Shortly thereafter, the firm settled a non-intervened False Claims Act case against Humana after defeating Humana's motion for summary judgment.

Appointed by President Bill Clinton in 1994 to the U.S. District Court for the District of Massachusetts, Judge Gertner (Ret.) brings decades of experience in employment discrimination, dispute resolution, and civil rights, among her many areas of expertise.

Judge Gertner is a graduate of Barnard College and Yale Law School where she was an editor on The Yale Law Journal. She received her M.A. in Political Science at Yale University and has been an instructor at Yale Law School, teaching sentencing and comparative sentencing institutions, since 1998. In September of 2011, Judge Gertner retired from the federal bench and joined the faculty at Harvard Law School.

Traci Buschner, GBB's managing partner said, "We are frankly honored to have Nancy join our firm ? she is a woman of boundless integrity, wit and empathy. Her life's work is ? and continues to be ? a powerful testament to lawyers seeking to make the world a better place for all. We look forward to fighting alongside her in important cases that deserve attention."

Beginning her career first as a Clerk for Chief Judge Luther Swygert of the U.S. Court of Appeals for the Seventh Circuit, then as one of the few women criminal defense and civil rights lawyers of her time, Judge Gertner is a fierce advocate for her clients and a trailblazer in the industry.

Judge Gertner said, "I am delighted to be of counsel to GBB.  Their whistleblower practice matches my public interest concerns, and their advocacy is creative and superb."

GBB is a boutique firm with a diverse group of attorneys, including a former Congressman, a former Commissioner of the OSHA Review Commission, a law professor who is a national expert on complex litigation and trial practice, a former attorney with the FDA and the EPA who also holds a medical license and continues to practice, and former federal law clerks and prosecutors.

The firm has offices in Washington, DC, Pennsylvania, and Delaware. In addition to the recent Celgene and Humana litigations, attorneys at the firm represented the lead whistleblower in U.S. ex rel. McCoyd v. Abbott Labs, which involved the recovery of $1.6 billion for the government; one of several whistleblowers bringing FCA cases against GlaxoSmithKline in 2012, which resulted in the recovery of $1.04 billion (U.S. ex rel. Graydon v. GSK);  one of the whistleblowers bringing FCA cases against Pfizer which resulted in the recovery of $2.3 billion (U.S. ex rel. DeMott v. Pfizer); the lead whistleblowers in U.S. ex rel. Sandler and Paris v. Pfizer, which resulted in recovery of $257.4 million; the lead whistleblower in U.S. ex rel. Szymoniak v. Bank of America, which resulted in the recovery of $95 million; three of the whistleblowers FCA cases against a large hospital chain (U.S. ex rel. Doghramji v. CHS), which resulted in the recovery of $98 million; the lead whistleblower in U.S. ex rel.  Kurnik v. Amgen, which resulted in the aggregate recovery of $30 million from Amgen, Inc., Omnicare, and PharMerica Corp.; and the whistleblower in U.S. ex rel. Abrahamsen v. Hudson Valley, which resulted in a recovery of $5.5 million to the federal government and state government. More information on GBB can be found at www.gbblegal.com

SOURCE Guttman, Buschner & Brooks PLLC

News published on 14 january 2019 at 11:30 and distributed by: